Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bleomycin-induced pulmonary toxicity.

K Jules-Elysee1, D A White

  • 1Division of Pulmonary Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.

Clinics in Chest Medicine
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Passive Freeze-Out of the Richtmyer-Meshkov Instability.

Physical review letters·2026
Same author

Suppression of Richtmyer-Meshkov Instability via Special Pairs of Shocks and Phase Transitions.

Physical review letters·2024
Same author

Pediatric Cardiology Fellowship Standards for Training in Exercise Medicine and Curriculum Outline.

Pediatric cardiology·2022
Same author

Intrapersonal, interpersonal and environmental correlates of moderate to vigorous physical activity and sedentary time in adolescents with intellectual and developmental disabilities.

Journal of intellectual disability research : JIDR·2022
Same author

Changes in physical activity across a 6-month weight loss intervention in adolescents with intellectual and developmental disabilities.

Journal of intellectual disability research : JIDR·2021
Same author

Exploring the effectiveness of an 18-month weight management intervention in adults with Down syndrome using propensity score matching.

Journal of intellectual disability research : JIDR·2020
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Bleomycin can cause lung damage, leading to interstitial pneumonitis and fibrosis. This review covers clinical presentation, diagnosis, and prognosis of this serious side effect.

Area of Science:

  • Pulmonary Medicine
  • Oncology
  • Toxicology

Background:

  • Bleomycin is a chemotherapy agent with known pulmonary toxicity.
  • Interstitial pneumonitis is a recognized complication, potentially progressing to fibrosis.
  • Risk factors for bleomycin-induced lung injury are not fully elucidated.

Purpose of the Study:

  • To describe the clinical, radiographic, and pathologic features of bleomycin-induced interstitial fibrosis.
  • To discuss the prognosis and management of this adverse event.
  • To evaluate the utility of pulmonary function tests in monitoring bleomycin toxicity.

Main Methods:

  • Literature review of bleomycin-induced pulmonary toxicity.
  • Analysis of clinical case reports and pathological findings.

Related Experiment Videos

  • Discussion of diagnostic criteria and prognostic indicators.

    • Main Results:

    • Bleomycin-induced interstitial fibrosis presents with varied clinical and radiographic findings.
    • Pathologic examination reveals characteristic interstitial inflammation and fibrosis.
    • Pulmonary function tests can aid in early detection of lung injury.

    Conclusions:

    • Bleomycin poses a significant risk of interstitial pneumonitis and fibrosis.
    • Early recognition and monitoring are crucial for managing bleomycin-induced lung toxicity.
    • Pulmonary function tests are valuable tools for patient surveillance.